Cooke W J, Berndt W O, Mudge G H
J Pharmacol Exp Ther. 1975 Mar;192(3):618-29.
In rats, hepatic dysfunction was induced with CCl4, SKF 525-A, taurolithocholic acid and alpha-naphthylisothiocyanate and by acute and chronic surgical ligation of the bile duct. Biliary and urinary excretion of 125I-labeled iopanoate was measured after a standard i.v. dose. In the absence of normal biliary excretion, the amount excreted in the urine varied over a wide range (0.25-11.2 percent of the dose), with highest rates of urinary excretion occurring after alpha-naphthylisothiocyanate and chronic stasis. Drug disposition was further determined by tissue analysis of liver and kidney. The results indicate that, for a drug that is normally almost exclusively excreted by the bile, in the presence of hepatic dysfunction the amount excreted by the alternate urinary route depends on the type of the induced hepatic disorder. The intrarenal distribution of 125I-radioactivity is strongly influenced by its plasma concentration rather than just by the rate of excretion in the urine.
在大鼠中,通过四氯化碳、SKF 525 - A、牛磺石胆酸和α-萘异硫氰酸酯以及急性和慢性胆管结扎诱导肝功能障碍。静脉注射标准剂量后,测量125I标记碘番酸的胆汁和尿液排泄量。在没有正常胆汁排泄的情况下,尿液中排泄的量在很宽的范围内变化(占剂量的0.25 - 11.2%),在α-萘异硫氰酸酯处理和慢性胆汁淤积后尿液排泄率最高。通过肝脏和肾脏的组织分析进一步确定药物处置情况。结果表明,对于一种通常几乎完全通过胆汁排泄的药物,在存在肝功能障碍的情况下,通过替代的尿液途径排泄的量取决于所诱导的肝脏疾病的类型。125I放射性在肾脏内的分布受其血浆浓度的强烈影响,而不仅仅取决于尿液中的排泄率。